MYL is doing no development work on the drug, as far as I know, so the ANDA is based on the same Copaxone knockoff that Natco sells in India and Ukraine.
Still, I don't think MYL's Copaxone ANDA is a hoax in the sense that Teva's Lovenox ANDA was.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”